top of page

Latest News

24.3.26

CERTAINTY Annual Meeting 2026 brings consortium together in Basel

Two days of collaboration and strategic alignment driving the project forward

CERTAINTY Annual Meeting 2026 brings consortium together in Basel

27.2.26

CERTAINTY at the 8th European CAR T-Cell Meeting

Three talks, three posters, and strong engagement at Europe’s leading CAR T cell scientific forum

CERTAINTY at the 8th European CAR T-Cell Meeting

16.2.26

CERTAINTY Hackathon 2026

Three days of intensive collaboration to strengthen data harmonisation, federated learning readiness, and prototype development

CERTAINTY Hackathon 2026

23.1.26

CERTAINTY enters Year 3: Strength in collaboration

Advancing cross-sector collaboration on the virtual twin for CAR T cell therapy, CERTAINTY enters its third year with ongoing implementation across work packages

CERTAINTY enters Year 3: Strength in collaboration

19.12.25

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma

New research in Cancer Cell links CD4 CAR T cells to outcomes and side effects in multiple myeloma

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
Key visuals (2).png

© Artur - stock.adobe.com / Fraunhofer IZI

© 2026 by Collaborate Project Management GmbH.

  • LinkedIn
  • Youtube

For further information on the CERTAINTY project, feel free to contact us through email or keep up with our latest updates by following our social media channels.  

 

Email: info@certainty-virtualtwin.eu

Funded by the European Union Logo

This project was funded by the European Union under Grant Agreement number 101136379. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

bottom of page